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ing the year follow-up were significantly higher for pa-
tients beginning treatment with a TCA than with a SSRI,
101.7 (SD 68.9) versus 81.6 (SD 63.5). Controlling for
confounders, males had fewer absences than females. La-
bor union members had significantly more absences than
did non-union workers. Initiating treatment with a TCA
resulted in nine additional absences compared to those
beginning treatment with a SSRI. CONCLUSIONS:
Treatment of depression with antidepressants appears to
lead to improved work outcomes through decreased ab-
senteeism. Initiating treatment with a SSRI as opposed to
a TCA may reduce the indirect costs of this disease in
terms of time away from work.
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Pharmacists have been working to help patients better
manage their health through disease state management
(DSM) programs. Because third party payers have been
reluctant to provide reimbursement for these services,
pharmacists are starting to bill the patient for payment. A
better understanding of who to target and how much to
charge for DSM programs would be beneficial to phar-
macists in developing and providing these programs. OB-
JECTIVE: The purpose of this study was to determine
what factors influence patient willingness to pay (WTP)
for a diabetes DSM program. METHODS: One hundred
fifty-five adult patients with diabetes were surveyed by
mail on the following factors to determine their effect on
WTP for a diabetes DSM program: patient satisfaction
with pharmacy services, health care utilization (hospital-
izations and emergency room visits), perceived need for
DSM, and sociodemographic factors. RESULTS: Patients
were willing to pay on average $27.80 (SD  $31.80) for
a one hour diabetes DSM consultation with the pharma-
cist. A regression model revealed that several factors sig-
nificantly (P  0.05) influenced patient WTP. Patients
who were likely to pay more for a diabetes DSM had a
greater perceived need for the service (P  0.004), had
more emergency room visits (P  0.0001), were more
likely to be male (P  0.009), were more likely to be
older (P  0.046), and had higher incomes (P  0.001)
This model was significant (P  0.0001) with 32 percent
of the variance explained. Although patient satisfaction
was not significant, it was positively correlated with
WTP. CONCLUSIONS: The project results may be use-
ful to pharmacists when determining the level of payment
for services, as well as targeting specific individuals and
tailoring DSM programs to meet diabetic patients’ needs.
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OBJECTIVE: The twofold purpose of the study was to:
1) develop health state descriptions of diabetic peripheral
neuropathy (DPN) and its complications for a new utility
instrument, and 2) use these descriptions to assess patient
preferences for health states associated with disease pro-
gression in DPN. METHODS: Development and pilot
testing of seven standardized health state scenarios de-
scribing disease progression and complications in DPN
have previously been presented. These seven states are
mild neuropathy, painful neuropathy, severe neuropathy,
mild ulcer, severe ulcer, minor amputation (toe) and ma-
jor amputation (below the knee). Patients between the
ages of 18 and 80 years were recruited from registries of
diabetic patients at the University of Washington Medi-
cal Center and the Seattle VA. Patients with a history of
DPN symptoms or complications were excluded. Each
patient completed a computer interview using the U-Titer
II utility measurement software. Both a rating scale (RS)
and a standard gamble (SG) technique were used to
quantify patient preferences for standardized descriptions
of the seven health states. RESULTS: 52 patients com-
pleted the 60-minute exercise. Overall, the mean utilities
for the seven health states were lower with the RS (0.86
to 0.27) when compared to the SG (0.87 to 0.61). The
preference scores followed a logical, decreasing order, in
accordance with severity, with the exception of the utility
for minor amputation being higher than for severe ulcer.
Neither previous knowledge of DPN nor demographic
characteristics were significant predictors of utility. CON-
CLUSIONS: This study has reported on the development
and evaluation of a new preference-based instrument for
use in DPN.
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Traditionally, bronchodilation with theophylline has
been a mainstay of treatment for persistent asthma. Cur-
rent treatment guidelines, however, call for reliance on
anti-inflammatory therapy and recommend that theo-
phylline and other long-acting bronchodilators be re-
